BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2296325)

  • 21. Factors influencing outcome of treatment with zidovudine of patients with AIDS in Australia. The Australian Zidovudine Study Group.
    Swanson CE; Cooper DA
    AIDS; 1990 Aug; 4(8):749-57. PubMed ID: 1979744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival trends for patients with AIDS.
    Lemp GF; Payne SF; Neal D; Temelso T; Rutherford GW
    JAMA; 1990 Jan; 263(3):402-6. PubMed ID: 2294307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival experience among patients with AIDS receiving zidovudine. Follow-up of patients in a compassionate plea program.
    Creagh-Kirk T; Doi P; Andrews E; Nusinoff-Lehrman S; Tilson H; Hoth D; Barry DW
    JAMA; 1988 Nov; 260(20):3009-15. PubMed ID: 3263514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zidovudine-induced anaemia in HIV/AIDS.
    Sharma SK
    Indian J Med Res; 2010 Oct; 132():359-61. PubMed ID: 20966512
    [No Abstract]   [Full Text] [Related]  

  • 25. FDA approves AZT for pediatric AIDS patients under 13.
    Oncology (Williston Park); 1990 Feb; 4(2):96. PubMed ID: 2143675
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex.
    Dournon E; Matheron S; Rozenbaum W; Gharakhanian S; Michon C; Girard PM; Perronne C; Salmon D; De Truchis P; Leport C
    Lancet; 1988 Dec; 2(8623):1297-302. PubMed ID: 2904016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of outcome in AIDS patients receiving zidovudine.
    Steinberg JP; Spear JB; Murphy RL; Wallemark CB; Benson CA; Kessler HA; Pottage JC; Phair JP
    J Acquir Immune Defic Syndr (1988); 1989; 2(3):229-34. PubMed ID: 2524583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group.
    Lundgren JD; Phillips AN; Pedersen C; Clumeck N; Gatell JM; Johnson AM; Ledergerber B; Vella S; Nielsen JO
    JAMA; 1994 Apr; 271(14):1088-92. PubMed ID: 8151850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profound cytopenia secondary to azidothymidine.
    Forester G
    N Engl J Med; 1987 Sep; 317(12):772. PubMed ID: 3476852
    [No Abstract]   [Full Text] [Related]  

  • 30. Failure to maintain high-dose treatment regimens during long-term use of zidovudine in patients with symptomatic human immunodeficiency virus type 1 infection.
    van Leeuwen R; van den Hurk PJ; Jöbsis GJ; van der Wouw PA; Reiss P; Eeftinck Schattenkerk JK; Danner SA; Lange JM
    Genitourin Med; 1990 Dec; 66(6):418-22. PubMed ID: 2125023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ungual pigmentation in patients with AIDS treated with zidovudine].
    Ramos C; Arazo P; García Aranda A; Franco JM; Samperiz P; Aguirre JM; Muñoz JR
    Rev Clin Esp; 1990 Jun; 187(2):94. PubMed ID: 2152548
    [No Abstract]   [Full Text] [Related]  

  • 32. Zidovudine therapy and health resource utilization in AIDS.
    Moore RD; Hidalgo J; Bareta JC; Chaisson RE
    J Acquir Immune Defic Syndr (1988); 1994 Apr; 7(4):349-54. PubMed ID: 8133446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epoetin alpha approved for anemic AIDS patients.
    J Am Osteopath Assoc; 1991 Jun; 91(6):538. PubMed ID: 1874651
    [No Abstract]   [Full Text] [Related]  

  • 34. Zidovudine and the natural history of AIDS.
    N Engl J Med; 1991 Oct; 325(18):1311-3. PubMed ID: 1922230
    [No Abstract]   [Full Text] [Related]  

  • 35. Influence of treatment with zidovudine (ZDV) on the long-term survival of AIDS patients.
    Buira E; Gatell JM; Miró JM; Batalla J; Zamora L; Mallolas J; Aznar E; Soriano E; San Miguel JG
    J Acquir Immune Defic Syndr (1988); 1992; 5(7):737-42. PubMed ID: 1613674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excessive growth of eyelashes in a patient with AIDS being treated with zidovudine.
    Klutman NE; Hinthorn DR
    N Engl J Med; 1991 Jun; 324(26):1896. PubMed ID: 2041557
    [No Abstract]   [Full Text] [Related]  

  • 37. Elective blood transfusions for AIDS patients in the emergency department: problems delineated and solutions and alternatives offered by quality assurance.
    Stangby A; Herd K
    J Emerg Nurs; 1990; 16(6):382-5. PubMed ID: 2266641
    [No Abstract]   [Full Text] [Related]  

  • 38. Survival for women and men with AIDS.
    Lemp GF; Hirozawa AM; Cohen JB; Derish PA; McKinney KC; Hernandez SR
    J Infect Dis; 1992 Jul; 166(1):74-9. PubMed ID: 1607710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Periportal fibrosis secondary to transfusion siderosis in two patients with acquired immune deficiency syndrome (AIDS) treated with zidovudine--a confusing ultrasound appearance.
    Wetton CW; Goldin R; Crofton ME
    Clin Radiol; 1993 Aug; 48(2):125-6. PubMed ID: 8004891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral mucosa pigmentation: a new side effect of azidothymidine therapy in patients with acquired immunodeficiency syndrome.
    Tadini G; D'Orso M; Cusini M; Alessi E
    Arch Dermatol; 1991 Feb; 127(2):267-8. PubMed ID: 1991000
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.